O95819 (M4K4_HUMAN) Homo sapiens (Human)
Mitogen-activated protein kinase kinase kinase kinase 4 UniProtKBInterProSTRINGInteractive Modelling
1239 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6);
2 identical sequences: Pan troglodytes: A0A6D2VV77, A0A2I3SJ61
It is possible new templates exist for this target since these models were created.
Available Structures
17 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Apo Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4) | homo-2-mer | 100 | 1×DMS; | |||
| MAP4K4 in complex with inhibitor (compound 6) | homo-2-mer | 100.0 | 1×3D8; | |||
| MAP4K4 Bound to inhibitor compound 1 | homo-2-mer | 100.0 | 1×3C8; 1×MG; 1×MES; | |||
| MAP4K4 in complex with inhibitor (compound 16) | homo-2-mer | 100.0 | 1×MES; 1×NA; 1×3D9; | |||
| MAP4K4 in complex with inhibitor (compound 25) | homo-2-mer | 100.0 | 2×MG; 1×3DC; 1×MES; | |||
| MAP4K4 in complex with inhibitor (compound 31), N-[3-(4-AMINOQUINAZOLIN-6-YL)-5-FLUOROPHENYL]-2-(PY… | homo-2-mer | 100.0 | 1×MES; 1×MG; 1×2QT; | |||
| Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4) Bound to AMPPNP | homo-2-mer | 100 | 1×ANP; 3×MG; | |||
| MAP4K4 in complex with a pyridin-2(1H)-one derivative | homo-2-mer | 100.0 | 1×3XM; 1×MES; | |||
| MAP4K4 in complex with inhibitor GNE-495 | homo-2-mer | 100.0 | 1×MG; 1×MES; 1×4P4; | |||
| APO MAP4K4 T181E Phosphomimetic Mutant | homo-2-mer | 99.66 | 2×MES; 1×NA; | |||
| MAP4K4 T181E Mutant Bound to inhibitor compound 1 | homo-2-mer | 100.0 | 1×MES; 2×3C8; 2×MG; | |||
| MAP4K4 in complex with inhibitor (compound 29), 6-(2-FLUOROPYRIDIN-4-YL)PYRIDO[3,2-D]PYRIMIDIN-4-AM… | monomer | 100.0 | 1×MG; 1×MES; 1×2QU; | |||
| MAP4K4 in complex with an inhibitor | monomer | 100.0 | 1×5DF; | |||
| MAP4K4 in complex with inhibitor | monomer | 100.0 | 1×4QG; | |||
| MAP4K4 in complex with inhibitor | monomer | 100.0 | 1×6HH; | |||
| MAP4K4 in complex with inhibitor (compound 22), 6-(3-CHLOROPHENYL)QUINAZOLIN-4-AMINE | monomer | 100.0 | 1×MES; 1×NA; 1×2QV; | |||
| MAP4K4 in complex with inhibitor compound 12 (N3-methyl-10-(3-methyl-3-(5-methyloxazol-2-yl)but-1-y… | monomer | 100.0 | 1×9X4; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4obp.3.A | homo-2-mer | 0.76 | 1×MG; 1×MES; 1×2QU; | 100.00 | ||
5 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 2x7f.1.A | monomer | 0.74 | 91.36 | |||
| Isoform 3 | 4u41.1.A | monomer | 0.74 | 1×3C8; 1×MG; 1×MES; | 100.00 | ||
| Isoform 4 | 2x7f.1.A | monomer | 0.74 | 91.36 | |||
| Isoform 5 | 2x7f.1.A | monomer | 0.74 | 91.38 | |||
| Isoform 6 | 2x7f.1.A | monomer | 0.74 | 91.38 | |||